MedWatch

Negative impact on Demant from Russia's war won't get any worse, says CEO

The hearing aid manufacturer has already written off its activities in Russia, which is why the ongoing conflict won’t end up affecting the company more than the DKK 100m (USD 14m) negative impact it has already accounted for.

Søren Nielsen, CEO of Demant | Photo: Demant / PR

Demant has put a figure on how much it expects to be affected by Russia’s invasion of Ukraine, and the subsequent effects of war, in 2022 -- a negative impact of DKK 100m (USD 14m) on the firm’s operating result.

In Tuesday’s first quarterly report, Demant maintained its full-year guidance after having calculated this impact into its expectations.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs